Ritter Pharmaceuticals, Inc.
(NASDAQ : RTTR)

( )
RTTR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
6.95%20.6214.1%$121.33m
MDCOMedicines Company
-0.66%52.0120.3%$106.13m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.97%114.506.2%$90.18m
AMRNAmarin Corporation Plc Sponsored ADR
2.08%15.221.8%$82.95m
PRGOPerrigo Co. Plc
2.83%53.476.8%$56.22m
JAZZJazz Pharmaceuticals Plc
0.60%118.672.3%$53.75m
SAGESAGE Therapeutics, Inc.
3.37%140.558.6%$52.51m
PCRXPacira Pharmaceuticals, Inc.
2.50%37.6910.5%$44.41m
UTHRUnited Therapeutics Corporation
1.41%81.8914.3%$40.50m
CTLTCatalent Inc
2.01%48.632.4%$35.04m
HZNPHorizon Pharma plc
2.73%27.066.6%$32.50m
ICLRICON Plc
-0.20%142.184.1%$32.03m
ICPTIntercept Pharmaceuticals, Inc.
1.09%59.5516.9%$30.63m
AERIAerie Pharmaceuticals, Inc.
13.71%20.156.8%$27.15m
ENDPEndo International Plc
3.49%3.718.8%$26.10m

Company Profile

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.